Pocket Erosion Four Months After ICD Implant
A 55-year-old woman with nonischemic cardiomyopathy (LVEF 30%) received a dual-chamber ICD 4 months ago. She presents with a 2-cm area of erythema over the generator pocket and a small sinus tract; the edge of the generator is visible through thin skin. She is afebrile, her white blood cell count is normal, and blood cultures are negative. Device interrogation shows normal pacing and sensing parameters with no shocks. She lives 3 hours from the implanting center and is reluctant to have the entire system removed. She asks whether the pocket can be opened, cleaned, and closed over the existing device.
1. What is the appropriate management recommendation, and why is pocket revision alone inappropriate?
Read the worked answer
This is generator erosion with likely pocket infection, even though she is afebrile and blood cultures are negative. The visible generator and sinus tract indicate that the pocket is no longer intact, and the device is contaminated. Pocket revision alone, such as cleaning and closing the skin over the existing generator, has a high failure rate and risks progression to deeper infection, bacteremia, endocarditis, and lead infection. Once the device erodes through the skin, the entire system, including the leads, should be considered contaminated.
The appropriate recommendation is complete system extraction by an experienced team, with admission for intravenous antibiotics and monitoring. Blood and pocket tissue cultures should be obtained, and echocardiography should be performed to evaluate for lead vegetations, especially if there is any bacteremia. Temporary pacing should be arranged if she is pacing-dependent. The extraction should not be delayed for a trial of conservative therapy.
2. How should the timing and type of reimplant be decided?
Read the worked answer
Reimplantation should be delayed until the patient is clinically stable and cultures are negative. In a patient without bacteremia or valvular infection, reimplantation is often possible after about 3–7 days of antibiotics, but the exact timing depends on culture results, fever, and the clinical course. If cultures are positive or there is endocarditis or lead vegetation, a longer course of intravenous antibiotics is needed, and reimplant may be delayed for days to weeks.
The choice of new system depends on pacing need and arrhythmia risk. If she needs bradycardia pacing, options include a contralateral transvenous system, a leadless pacemaker if only ventricular pacing is required, or an epicardial system. If she does not need pacing, a subcutaneous ICD avoids transvenous leads and may reduce infection risk, but it cannot provide bradycardia pacing or ATP. A contralateral transvenous ICD is also reasonable if venous access is adequate. The patient's preference, anatomy, and prior lead performance should be considered, and she should be counseled about the risk of recurrent infection.
3. What should the patient be told about the rationale for extraction and the risks of refusing it?
Read the worked answer
She should be told that the device has eroded through the skin and is contaminated, even though she feels well and her blood tests are normal. Keeping the device in place risks a serious bloodstream infection, infection of the leads or heart valves, and a much more difficult extraction later. Pocket revision alone often fails and may allow infection to spread.
Extraction carries risks, including bleeding, pneumothorax, lead fracture, vascular injury, and, rarely, emergency surgery, so it should be performed by an experienced team with surgical backup. The benefits of removing the infected system generally outweigh these risks. If she refuses, she should understand that she is accepting a substantial risk of serious infection and that the device may need urgent removal later under less favorable conditions. Document the discussion and involve shared decision-making.